Publications

2024

• Apixaban to Prevent Recurrence After Cryptogenic StrokeChi K, Nanna M, Nanna M. Apixaban to Prevent Recurrence After Cryptogenic Stroke. JAMA 2024, 331: 1965-1966. PMID: 38739398, DOI: 10.1001/jama.2024.6851.
• Design and development of the DE-SPECT system: a clinical SPECT system for broadband multi-isotope imaging of peripheral vascular diseaseZannoni E, Sankar P, Jin Y, Liu C, Sinusas A, Metzler S, Meng L. Design and development of the DE-SPECT system: a clinical SPECT system for broadband multi-isotope imaging of peripheral vascular disease. Physics In Medicine And Biology 2024, 69: 125016. PMID: 38815617, PMCID: PMC11167601, DOI: 10.1088/1361-6560/ad5266.
• Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil studyCamargos A, Barreto S, Brant L, Ribeiro A, Dhingra L, Aminorroaya A, Bittencourt M, Figueiredo R, Khera R. Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study. Open Heart 2024, 11: e002762. PMID: 38862252, PMCID: PMC11168182, DOI: 10.1136/openhrt-2024-002762.
• Primary outcomes of the enhanced, EHR-facilitated cancer symptom control (E2C2) cluster-randomized, stepped wedge, pragmatic trial.Cheville A, Pachman D, Kroenke K, Herrin J, Grzegorczyk V, Mitchell S, Griffin J, Ridgeway J, Austin J, Smith A, Chlan L, Tofthagen C, Ruddy K. Primary outcomes of the enhanced, EHR-facilitated cancer symptom control (E2C2) cluster-randomized, stepped wedge, pragmatic trial. Journal Of Clinical Oncology 2024, 42: lba12006-lba12006. DOI: 10.1200/jco.2024.42.17_suppl.lba12006.
• Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows StrongerMaurer M, Miller E, Ruberg F. Addressing Health Disparities—The Case for Variant Transthyretin Cardiac Amyloidosis Grows Stronger. JAMA 2024, 331: 1809-1811. PMID: 38734953, DOI: 10.1001/jama.2024.2868.
• Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission MeasureKyanko K, Sahay K, Wang Y, Li S, Schreiber M, Hager M, Myers R, Johnson W, Zhang J, Krumholz H, Suter L, Triche E. Incorporating Medicare Advantage Admissions Into the CMS Hospital-Wide Readmission Measure. JAMA Network Open 2024, 7: e2414431. PMID: 38829614, PMCID: PMC11148674, DOI: 10.1001/jamanetworkopen.2024.14431.
• Observational study protocol for an arrhythmia notification featureKumar S, Weinstein J, Melchinger H, Smith A, Capodilupo E, Akar J, Garg K, O’Connor K, Staunton M, Martin M, Akhlaghi N, Edeh O, Perez S, Lee V, Lee K, Wilson F. Observational study protocol for an arrhythmia notification feature. BMJ Open 2024, 14: e075110. PMID: 38830741, PMCID: PMC11149124, DOI: 10.1136/bmjopen-2023-075110.
• Comorbidity Differences Associated with Long-Term Amputation and Repeat Revascularization Rates after Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and EthnicityAltin S, Parise H, Hess C, Rosenthal N, Julien H, Curtis J. Comorbidity Differences Associated with Long-Term Amputation and Repeat Revascularization Rates after Femoropopliteal Artery Intervention for Intermittent Claudication by Sex, Race, and Ethnicity. The American Journal Of Cardiology 2024 PMID: 38834142, DOI: 10.1016/j.amjcard.2024.05.021.
• A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and ProgressionOikonomou E, Holste G, Yuan N, Coppi A, McNamara R, Haynes N, Vora A, Velazquez E, Li F, Menon V, Kapadia S, Gill T, Nadkarni G, Krumholz H, Wang Z, Ouyang D, Khera R. A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression. JAMA Cardiology 2024, 9: 534-544. PMID: 38581644, PMCID: PMC10999005, DOI: 10.1001/jamacardio.2024.0595.
• Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic ShockJamil Y, Park D, Rao S, Ahmad Y, Sikand N, Bosworth H, Coles T, Damluji A, Nanna M, Samsky M. Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock. JACC Advances 2024, 3: 100949. DOI: 10.1016/j.jacadv.2024.100949.
• SPPADE symptom prevalence and severity in a diverse sample of patients living with metastatic cancers.Pachman D, Ruddy K, Grzegorczyk V, Kroenke K, Griffin J, Ridgeway J, Chlan L, Tofthagen C, Leventakos K, Strand J, Austin J, Smith A, Mitchell S, Herrin J, Cheville A. SPPADE symptom prevalence and severity in a diverse sample of patients living with metastatic cancers. Journal Of Clinical Oncology 2024, 42: 11108-11108. DOI: 10.1200/jco.2024.42.16_suppl.11108.
• Dyspnea in a patient with metastatic breast cancerTarras E, Sen S, Wang H, Singh I. Dyspnea in a patient with metastatic breast cancer. CHEST Pulmonary 2024, 100074. DOI: 10.1016/j.chpulm.2024.100074.
• Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion.Friedman DJ, Du C, Zimmerman S, Tan Z, Lin Z, Vemulapalli S, Kosinski AS, Piccini JP, Pereira L, Minges KE, Faridi KF, Masoudi FA, Curtis JP, Freeman JV. Procedure Volume and Outcomes With WATCHMAN Left Atrial Appendage Occlusion. Circ Cardiovasc Interv 2024, 17: e013466. PMID: 38889251, DOI: 10.1161/CIRCINTERVENTIONS.123.013466.
• Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasiaWang D, Ito S, Waldron C, Butt A, Zhang E, Krumholz H, Al-Samkari H, Goshua G. Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia. Blood Advances 2024, 8: 2835-2845. PMID: 38537061, PMCID: PMC11176968, DOI: 10.1182/bloodadvances.2024012589.
• Endothelial-adipocyte Cx43 mediated gap junctions can regulate adiposityLuse M, Dunaway L, Nyshadham S, Carvalho A, Sedovy M, Ruddiman C, Tessema R, Hirschi K, Johnstone S, Isakson B. Endothelial-adipocyte Cx43 mediated gap junctions can regulate adiposity. Function 2024, zqae029. DOI: 10.1093/function/zqae029.
• Optimal Blood Pressure Control for Optimal Longevity: Balancing Cardiovascular and Cognitive Outcomes.Lu Y, Ma Y. Optimal Blood Pressure Control for Optimal Longevity: Balancing Cardiovascular and Cognitive Outcomes. Circulation Cardiovascular Quality And Outcomes 2024, e011135. PMID: 38813694, DOI: 10.1161/circoutcomes.124.011135.
• Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc AnalysisL’Italien G, Oikonomou E, Khera R, Potashman M, Beiner M, Maclaine G, Schmahmann J, Perlman S, Coric V. Video-Based Kinematic Analysis of Movement Quality in a Phase 3 Clinical Trial of Troriluzole in Adults with Spinocerebellar Ataxia: A Post Hoc Analysis. Neurology And Therapy 2024, 1-15. PMID: 38814532, DOI: 10.1007/s40120-024-00625-6.
• Links Between Obstructive Sleep Apnea and Myocardial Blood Flow Changes Impacting Adverse Cardiovascular Disease-related OutcomesAneni E, Sinusas A, Emokpae M, Thorn S, Yaggi H, Miller E. Links Between Obstructive Sleep Apnea and Myocardial Blood Flow Changes Impacting Adverse Cardiovascular Disease-related Outcomes. Current Cardiology Reports 2024, 1-12. PMID: 38806976, DOI: 10.1007/s11886-024-02072-z.
• Impact of COVID-19 pandemic on physician-scientist trainees to faculty one year into the pandemicObradovic A, Toubat O, Chen N, Siebert A, Jansen C, Christophers B, Leveille E, Noch E, Kwan J. Impact of COVID-19 pandemic on physician-scientist trainees to faculty one year into the pandemic. BMC Medical Education 2024, 24: 587. PMID: 38807106, PMCID: PMC11134762, DOI: 10.1186/s12909-024-05541-9.
• Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF TrialFudim M, Cyr D, Ward J, Hernandez A, Lepage S, Morrow D, Sharma K, Claggett B, Starling R, Velazquez E, Williamson K, Desai A, Zieroth S, Solomon S, Braunwald E, Mentz R, Investigators P. Association of Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic Hypotension: The PARAGLIDE-HF Trial. Journal Of Cardiac Failure 2024 PMID: 38802053, DOI: 10.1016/j.cardfail.2024.04.030.
• Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D TrialPark D, Jamil Y, Moumneh M, Batchelor W, Nanna M, Damluji A. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial. The American Journal Of Cardiology 2024, 223: 58-69. PMID: 38797195, DOI: 10.1016/j.amjcard.2024.05.016.
• Volenrelaxin (LY3540378) increases Renal Plasma Flow: A Randomized Phase 1 TrialSan Tham L, Heerspink H, Wang X, Verdino P, Saifan C, Benson E, Goldsmith P, Wang Z, Testani J, Haupt A, Sam F, Cherney D. Volenrelaxin (LY3540378) increases Renal Plasma Flow: A Randomized Phase 1 Trial. Nephrology Dialysis Transplantation 2024, gfae112. PMID: 38782726, DOI: 10.1093/ndt/gfae112.
• The Interactive Effects of Rejection and Rumination on Diurnal Cortisol among Adolescent Girls: A Preliminary Daily Diary StudyVergara-Lopez C, Scalco M, Gaffey A, Reid B, Bublitz M, Lee S, Gomez A, Mercado N, Stroud L. The Interactive Effects of Rejection and Rumination on Diurnal Cortisol among Adolescent Girls: A Preliminary Daily Diary Study. Cognitive Therapy And Research 2024, 1-8. DOI: 10.1007/s10608-024-10492-y.
• Finding the Optimal Strategy for Nonculprit Revascularization in Acute Myocardial Infarction: The Role of Angiography-Derived PhysiologyOdanovic N, Parikh R, Shah S. Finding the Optimal Strategy for Nonculprit Revascularization in Acute Myocardial Infarction: The Role of Angiography-Derived Physiology. Circulation Cardiovascular Interventions 2024, 17: e014129. PMID: 38771908, DOI: 10.1161/circinterventions.124.014129.
• Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients.Hosseini K, Behnoush AH, Khalaji A, Etemadi A, Soleimani H, Pasebani Y, Jenab Y, Masoudkabir F, Tajdini M, Mehrani M, Nanna MG. Machine learning prediction of one-year mortality after percutaneous coronary intervention in acute coronary syndrome patients. Int J Cardiol 2024, 409: 132191. PMID: 38777044, DOI: 10.1016/j.ijcard.2024.132191.
• FEASIBILITY OF AMULET OCCLUDER IMPLANTATION AFTER FAILED LEFT ATRIAL APPENDAGE OCCLUSION ATTEMPT: INSIGHTS FROM THE EMERGE LAA POST-APPROVAL STUDYMakkar A, Alkhouli M, Ellis C, Shah A, Coylewright M, Freeman J, Anderson J, Gage R, Lakkireddy D. FEASIBILITY OF AMULET OCCLUDER IMPLANTATION AFTER FAILED LEFT ATRIAL APPENDAGE OCCLUSION ATTEMPT: INSIGHTS FROM THE EMERGE LAA POST-APPROVAL STUDY. Heart Rhythm 2024 PMID: 38768843, DOI: 10.1016/j.hrthm.2024.05.004.
• StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using electronic health recordsLee H, Schwamm L, Sansing L, Kamel H, de Havenon A, Turner A, Sheth K, Krishnaswamy S, Brandt C, Zhao H, Krumholz H, Sharma R. StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using electronic health records. Npj Digital Medicine 2024, 7: 130. PMID: 38760474, PMCID: PMC11101464, DOI: 10.1038/s41746-024-01120-w.
• Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factorBrösecke F, Pfau A, Ermer T, Dein Terra Mota Ribeiro A, Rubenbauer L, Rao V, Burlein S, Genser B, Reichel M, Aronson P, Coca S, Knauf F. Interleukin-16 is increased in dialysis patients but is not a cardiovascular risk factor. Scientific Reports 2024, 14: 11323. PMID: 38760468, PMCID: PMC11101424, DOI: 10.1038/s41598-024-61808-7.
• SOFA score performs worse than age for predicting mortality in patients with COVID-19Sherak R, Sajjadi H, Khimani N, Tolchin B, Jubanyik K, Taylor R, Schulz W, Mortazavi B, Haimovich A. SOFA score performs worse than age for predicting mortality in patients with COVID-19. PLOS ONE 2024, 19: e0301013. PMID: 38758942, PMCID: PMC11101117, DOI: 10.1371/journal.pone.0301013.
• De Novo Elastin Assembly Alleviates Development of Supravalvular Aortic Stenosis.Ellis M, Riaz M, Huang Y, Anderson C, Hoareau M, Li X, Luo H, Lee S, Park J, Luo J, Batty L, Huang Q, Lopez C, Reinhardt D, Tellides G, Qyang Y. De Novo Elastin Assembly Alleviates Development of Supravalvular Aortic Stenosis. Arteriosclerosis Thrombosis And Vascular Biology 2024 PMID: 38752350, DOI: 10.1161/atvbaha.124.320790.
• Surveillance with Dual Non-invasive Testing for Acute Cellular Rejection After Heart Transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry (SHORE)Khush K, Hall S, Kao A, Raval N, Dhingra R, Shah P, Bellumkonda L, Ravichandran A, Van Bakel A, Uriel N, Patel S, Pinney S, DePasquale E, Baran D, Pinney K, Oreschak K, Kobulnik J, Shen L, Teuteberg J. Surveillance with Dual Non-invasive Testing for Acute Cellular Rejection After Heart Transplantation: Outcomes from the Surveillance HeartCare Outcomes Registry (SHORE). The Journal Of Heart And Lung Transplantation 2024 PMID: 38759766, DOI: 10.1016/j.healun.2024.05.003.
• On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.Kittipibul V, Mentz R, Clare R, Wojdyla D, Anstrom K, Eisenstein E, Ambrosy A, Goyal P, Skopicki H, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Greene S. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF. European Journal Of Heart Failure 2024 PMID: 38745502, DOI: 10.1002/ejhf.3293.
• Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpuraAllen C, Ito S, Butt A, Purcell A, Richmond R, Tormey C, Krumholz H, Cuker A, Goshua G. Cost-effectiveness of rapid vs in-house vs send-out ADAMTS13 testing for immune thrombotic thrombocytopenic purpura. Blood Advances 2024, 8: 2279-2289. PMID: 38502197, PMCID: PMC11116991, DOI: 10.1182/bloodadvances.2024012608.
• High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?See C, Kim Y, Park J, Wang Y, Reinhardt S, Shkolnik E, Faridi K, Lombo B, Bellumkonda L, McNamara R, Sugeng L, Hur D. High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT? International Journal Of Cardiology 2024, 409: 132174. PMID: 38754590, DOI: 10.1016/j.ijcard.2024.132174.
• Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and TreatmentTannu M, Hess C, Gutierrez J, Lopes R, Swaminathan R, Altin S, Rao S. Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment. Current Cardiology Reports 2024, 1-16. PMID: 38743352, DOI: 10.1007/s11886-024-02063-0.
• Sodium zirconium cyclosilicate in patients with HFrEF and hyperkalemia: REALIZE-K rationale, design, and baseline characteristicsKosiborod M, Cherney D, Connelly K, Desai A, Guimarães P, Kuthi L, Lala-Trindade A, Madrini V, Merkely B, Villota J, Squire I, Testani J, Vaclavik J, Verma S, Wranicz J, Dahl M, Eudicone J, Friberg L, Petrie M. Sodium zirconium cyclosilicate in patients with HFrEF and hyperkalemia: REALIZE-K rationale, design, and baseline characteristics. JACC Heart Failure 2024 PMID: 38878009, DOI: 10.1016/j.jchf.2024.05.003.
• Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear Imaging in Minority Populations) StudyWardhere A, Bampatsias D, Cohn E, Fine D, Freitas C, Gallegos C, Helmke S, Ionescu N, Ivrose J, Rodriguez C, Sabogal N, Fils S, Henry T, Teruya S, Ullah I, Kurian D, Raiszadeh F, Miller E, Ruberg F, Maurer M. Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear Imaging in Minority Populations) Study. Journal Of Cardiac Failure 2024 PMID: 38740174, DOI: 10.1016/j.cardfail.2024.04.019.
• Comparative Effectiveness of GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic RetinopathyBarkmeier A, Herrin J, Swarna K, Deng Y, Polley E, Umpierrez G, Galindo R, Ross J, Mickelson M, McCoy R. Comparative Effectiveness of GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy. Ophthalmology Retina 2024 PMID: 38735641, DOI: 10.1016/j.oret.2024.05.003.
• The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDKrumholz H, Sawano M, Bhattacharjee B, Caraballo C, Khera R, Li S, Herrin J, Coppi A, Holub J, Henriquez Y, Johnson M, Goddard T, Rocco E, Hummel A, Mouslmani M, Putrino D, Carr K, Carvajal-Gonzalez S, Charnas L, De Jesus M, Ziegler F, Iwasaki A. The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVID. The American Journal Of Medicine 2024 PMID: 38735354, DOI: 10.1016/j.amjmed.2024.04.030.
• Exosomes: A New Hope for Angiogenesis-Mediated Bone Regeneration.Lange M, Babczyk P, Tobiasch E. Exosomes: A New Hope for Angiogenesis-Mediated Bone Regeneration. Int J Mol Sci 2024, 25 PMID: 38791243, DOI: 10.3390/ijms25105204.
• Variability in Short-term Mortality Following Repair of Ruptured Abdominal Aortic Aneurysms Across Centers and PhysiciansRomain G, Wang K, Scierka L, Cleman J, Callegari S, Aboian E, Smolderen K, Mena-Hurtado C. Variability in Short-term Mortality Following Repair of Ruptured Abdominal Aortic Aneurysms Across Centers and Physicians. Journal Of Vascular Surgery 2024 PMID: 38729585, DOI: 10.1016/j.jvs.2024.05.004.
• Pulse2AI: An Adaptive Framework to Standardize and Process Pulsatile Wearable Sensor Data for Clinical ApplicationsHuang S, Jafari R, Mortazavi B. Pulse2AI: An Adaptive Framework to Standardize and Process Pulsatile Wearable Sensor Data for Clinical Applications. IEEE Open Journal Of Engineering In Medicine And Biology 2024, 5: 330-338. DOI: 10.1109/ojemb.2024.3398444.
• Multi-modality imaging for assessment of the microcirculation in peripheral artery disease: Bench to clinical practiceCallegari S, Feher A, Smolderen K, Mena-Hurtado C, Sinusas A. Multi-modality imaging for assessment of the microcirculation in peripheral artery disease: Bench to clinical practice. American Heart Journal Plus Cardiology Research And Practice 2024, 42: 100400. PMID: 38779485, PMCID: PMC11108852, DOI: 10.1016/j.ahjo.2024.100400.
• TAI-GAN: A Temporally and Anatomically Informed Generative Adversarial Network for early-to-late frame conversion in dynamic cardiac PET inter-frame motion correctionGuo X, Shi L, Chen X, Liu Q, Zhou B, Xie H, Liu Y, Palyo R, Miller E, Sinusas A, Staib L, Spottiswoode B, Liu C, Dvornek N. TAI-GAN: A Temporally and Anatomically Informed Generative Adversarial Network for early-to-late frame conversion in dynamic cardiac PET inter-frame motion correction. Medical Image Analysis 2024, 96: 103190. PMID: 38820677, PMCID: PMC11180595, DOI: 10.1016/j.media.2024.103190.
• Tracheostomy in Patients with Acute Myocardial Infarction and Respiratory Failure.Grammatico M, Banna S, Shahu A, Gastanadui M, Jimenez J, Heck C, Arias-Olson A, Thomas A, Ali T, Miller P. Tracheostomy in Patients with Acute Myocardial Infarction and Respiratory Failure. Journal Of Intensive Care Medicine 2024, 8850666241253202. PMID: 38715423, DOI: 10.1177/08850666241253202.
• Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention?Fezzi S, Ding D, Mahfoud F, Huang J, Lansky A, Tu S, Wijns W. Illusion of revascularization: does anyone achieve optimal revascularization during percutaneous coronary intervention? Nature Reviews Cardiology 2024, 1-11. PMID: 38710772, DOI: 10.1038/s41569-024-01014-0.
• Introducing the JAMA SummitBibbins-Domingo K, Angus D, Park H, Lewis R, Khera R, Zeis J, Flanagin A, Curfman G. Introducing the JAMA Summit. JAMA 2024, 331: 1451-1451. PMID: 38573798, DOI: 10.1001/jama.2024.5570.
• Utilization of Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid From 2016 to 2020Essa M, Ross J, Dhruva S, Desai N, Spatz E, Faridi K. Utilization of Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid From 2016 to 2020. Circulation Cardiovascular Quality And Outcomes 2024, 17: e010697. PMID: 38712553, DOI: 10.1161/circoutcomes.123.010697.
• Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.Bharadwaj A, Abu-Much A, Maini A, Zhou Z, Li Y, Batchelor W, Grines C, Baron S, Redfors B, Lansky A, Basir M, O'Neill W. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study. Circulation Cardiovascular Interventions 2024, e013503. PMID: 38708609, DOI: 10.1161/circinterventions.123.013503.
• Multi-Task Learning for Motion Analysis and Segmentation in 3D EchocardiographyTa K, Ahn S, Thorn S, Stendahl J, Zhang X, Langdon J, Staib L, Sinusas A, Duncan J. Multi-Task Learning for Motion Analysis and Segmentation in 3D Echocardiography. IEEE Transactions On Medical Imaging 2024, 43: 2010-2020. PMID: 38231820, DOI: 10.1109/tmi.2024.3355383.
• Seasonal variations in admissions for atrial fibrillation or atrial flutter in the Northeast and the Midwest regions of the United StatesPark D, Bittar-Carlini G, Kumar M, Jamil Y, Nanna M. Seasonal variations in admissions for atrial fibrillation or atrial flutter in the Northeast and the Midwest regions of the United States. Baylor University Medical Center Proceedings 2024, ahead-of-print: 1-9. DOI: 10.1080/08998280.2024.2346050.
• Abstract PO2-12-09: Insomnia, Pain, Anxiety, Distress, Fatigue, and Functional Impairment in Patients with Breast CancerRuddy K, Grzegorczyk V, Pachman D, Mitchell S, Liu B, Smith D, O'Sullivan C, Ehlers S, Herrin J, Rahman P, Cheville A. Abstract PO2-12-09: Insomnia, Pain, Anxiety, Distress, Fatigue, and Functional Impairment in Patients with Breast Cancer. Cancer Research 2024, 84: po2-12-09-po2-12-09. DOI: 10.1158/1538-7445.sabcs23-po2-12-09.
• Global considerations for informed consent with shared decision-making in the digital ageSt John E, Moore C, Pillarisetti R, Spatz E. Global considerations for informed consent with shared decision-making in the digital age. BMJ Evidence-Based Medicine 2024, bmjebm-2023-112740. PMID: 38697783, DOI: 10.1136/bmjebm-2023-112740.
• Complex Heart-Lung Ventilator Emergencies in the CICU.Lopez MP, Applefeld W, Miller E, Elliott A, Bennett C, Lee B, Barnett C, Solomon MA, Corradi F, Sionis A, Mireles-Cabodevila E, Tavazzi G, Alviar CL. Complex Heart-Lung Ventilator Emergencies in the CICU. Cardiol Clin 2024, 42: 253-271. PMID: 38631793, DOI: 10.1016/j.ccl.2024.02.010.
• Social Determinants of Health and Delivery of Rehabilitation to Older Adults During ICU HospitalizationJain S, Murphy T, Falvey J, Leo-Summers L, O’Leary J, Zang E, Gill T, Krumholz H, Ferrante L. Social Determinants of Health and Delivery of Rehabilitation to Older Adults During ICU Hospitalization. JAMA Network Open 2024, 7: e2410713. PMID: 38728030, PMCID: PMC11087837, DOI: 10.1001/jamanetworkopen.2024.10713.
• Fasting Duration Prior to Venography Is Associated with Stent Size in Patients with Iliac Vein CompressionSchultz K, Rodriguez P, Hamdi S, Attaran R, Lozada J, Huber S, Tonnessen B, Aboian E, Guzman R, Chaar C. Fasting Duration Prior to Venography Is Associated with Stent Size in Patients with Iliac Vein Compression. Journal Of Vascular Surgery Venous And Lymphatic Disorders 2024, 12: 101774. DOI: 10.1016/j.jvsv.2024.101774.
• C-19 | Vessel-Specific Analysis of Patients With Angina and No Obstructive Coronary Artery Disease Undergoing Coronary Function TestingLatif N, Cigarroa N, Maayah M, Kunnirickal S, Odanovic N, Pfau S, Kattan C, Shah S. C-19 | Vessel-Specific Analysis of Patients With Angina and No Obstructive Coronary Artery Disease Undergoing Coronary Function Testing. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101650. DOI: 10.1016/j.jscai.2024.101650.
• C-11 | Correlation Between Thermodilution-Derived Coronary Flow Reserve and Rubidium-82 PET Myocardial Flow Reserve in Patients Undergoing Invasive Coronary Function TestingCigarroa N, Abushouk A, Latif N, Gallegos C, Maayah M, Kunnirickal S, Odanovic N, Pfau S, Shah S. C-11 | Correlation Between Thermodilution-Derived Coronary Flow Reserve and Rubidium-82 PET Myocardial Flow Reserve in Patients Undergoing Invasive Coronary Function Testing. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101642. DOI: 10.1016/j.jscai.2024.101642.
• PO-05-130 DEMONSTRATING THE IMPACT OF LESION ORIENTATION ON ABLATION EFFICIENCY IN AN ANISOTROPIC MODEL OF PERSISTENT ATRIAL FIBRILLATIONReiss M, Mulimani M, Luther S, Akar J, Rappel W, Akar F, Hummel J. PO-05-130 DEMONSTRATING THE IMPACT OF LESION ORIENTATION ON ABLATION EFFICIENCY IN AN ANISOTROPIC MODEL OF PERSISTENT ATRIAL FIBRILLATION. Heart Rhythm 2024, 21: s535. DOI: 10.1016/j.hrthm.2024.03.1365.
• Calculation of Overall Hospital Quality Star Ratings With and Without Inclusion of the Peer Grouping StepGettel C, Bagshaw K, Qin L, Lin Z, Rothenberg E, Omotosho P, Goutos D, Herrin J, Suter L, Schreiber M, Fleisher L, Myers R, Venkatesh A. Calculation of Overall Hospital Quality Star Ratings With and Without Inclusion of the Peer Grouping Step. JAMA Network Open 2024, 7: e2411933. PMID: 38753326, PMCID: PMC11099678, DOI: 10.1001/jamanetworkopen.2024.11933.
• Development and multinational validation of an algorithmic strategy for high Lp(a) screeningAminorroaya A, Dhingra L, Oikonomou E, Saadatagah S, Thangaraj P, Vasisht Shankar S, Spatz E, Khera R. Development and multinational validation of an algorithmic strategy for high Lp(a) screening. Nature Cardiovascular Research 2024, 3: 558-566. DOI: 10.1038/s44161-024-00469-1.
• Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study.Shimbo D, Cohen M, McGoldrick M, Ensari I, Diaz K, Fu J, Duran A, Zhao S, Suls J, Burg M, Chaplin W. Translational Research of the Acute Effects of Negative Emotions on Vascular Endothelial Health: Findings From a Randomized Controlled Study. Journal Of The American Heart Association 2024, 13: e032698. PMID: 38690710, PMCID: PMC11179860, DOI: 10.1161/jaha.123.032698.
• Manifestations of human atherosclerosis across vascular bedsJovin D, Sumpio B, Greif D. Manifestations of human atherosclerosis across vascular beds. JVS-Vascular Insights 2024, 2: 100089. DOI: 10.1016/j.jvsvi.2024.100089.
• OR8-1 | Characterizing Ischemia and Nonobstructive Coronary Arteries With Invasive Coronary Function Testing: First Report From the DISCOVER INOCA Multicenter RegistryShah S, Tremmel J, Henry T, Smilowitz N, Prasad M, Kobayashi Y, Samuels B, Lerman A, Moses J, Pietras C, Zhang Z, Tirziu D, Parise H, Cristea E, Chamie D, Grubman D, Henrici K, Latif N, Cigarroa N, Lansky A. OR8-1 | Characterizing Ischemia and Nonobstructive Coronary Arteries With Invasive Coronary Function Testing: First Report From the DISCOVER INOCA Multicenter Registry. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101451. DOI: 10.1016/j.jscai.2024.101451.
• Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries: Design and Rationale of the DISCOVER INOCA Prospective, Multicenter RegistryShah S, Tremmel J, Henry T, Smilowitz N, Prasad M, Kobayashi Y, Henry G, Samady H, Samuels B, Lerman A, Moses J, Pietras C, Zhang Z, Tirziu D, Parise H, Cristea E, Chamié D, Grubman D, Henrici K, Matmusaeva E, Latif N, Cigarroa N, Lansky A. Determining the Cause of Coronary Vasomotor Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries: Design and Rationale of the DISCOVER INOCA Prospective, Multicenter Registry. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 102046. DOI: 10.1016/j.jscai.2024.102046.
• MP-470551-008 ATRIAL FIBRILLATION IN MICE WITH AMPK DELETION IS MEDIATED BY TRIGGERED ACTIVITY FROM THE PULMONARY VEIN JUNCTIONCacheux M, Velasco J, Wu X, Akar J, Young L, Akar F. MP-470551-008 ATRIAL FIBRILLATION IN MICE WITH AMPK DELETION IS MEDIATED BY TRIGGERED ACTIVITY FROM THE PULMONARY VEIN JUNCTION. Heart Rhythm 2024, 21: s107. DOI: 10.1016/j.hrthm.2024.03.1772.
• PO-05-168 CARDIOMYOCYTE STIM1 EXPRESSION REGULATES POST-ISCHEMIC CARDIAC FUNCTION BY CONTROLLING METABOLIC PROCESSES AND MITOCHONDRIAL ULTRASTRUCTURECacheux M, Wu X, Akar F. PO-05-168 CARDIOMYOCYTE STIM1 EXPRESSION REGULATES POST-ISCHEMIC CARDIAC FUNCTION BY CONTROLLING METABOLIC PROCESSES AND MITOCHONDRIAL ULTRASTRUCTURE. Heart Rhythm 2024, 21: s570-s571. DOI: 10.1016/j.hrthm.2024.03.1439.
• LB-8 | First in Human Safety and Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (The ENGULF Trial)Kobayashi T, Secemsky E, Klein A, Faintuch S, Bulman J, Weinstein J, Bitton-Faiwiszewski Y, Bisharat M, Metzger D, Rosenberg R, Weinberg I, Vadlamudi V, Matthai W, Saleh A, Cristea E, Lansky A, Giri J. LB-8 | First in Human Safety and Feasibility of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (The ENGULF Trial). Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101877. DOI: 10.1016/j.jscai.2024.101877.
• A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF)Kobayashi T, Secemsky E, Klein A, Faintuch S, Bulman J, Weinstein J, Bitton-Faiwiszewski Y, Bisharat M, Metzger D, Rosenberg R, Weinberg I, Vadlamudi V, Matthai W, Saleh A, Cristea E, Lansky A, Giri J. A Safety and Feasibility Single-Arm Study of a Novel Catheter Thrombectomy Device for the Treatment of Pulmonary Embolism (ENGULF). Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 102049. DOI: 10.1016/j.jscai.2024.102049.
• Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized TrialsTalanas G, Laconi A, Kereiakes D, Merella P, Reardon M, Spano A, Petretto G, Lauriola F, Casula M, Micheluzzi V, Isgender M, Chatzizisis Y, Farkouh M, Lansky A, Piazza N, Portoghese M, Casu G, Navarese E. Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-Analysis of Randomized Trials. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 102143. DOI: 10.1016/j.jscai.2024.102143.
• F-18 | Comparison of the Safety and Efficacy of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysisSchwartz A, Shah Y, Huang H, Francese D, Shah T, Lansky A. F-18 | Comparison of the Safety and Efficacy of Endovascular Interventions for the Treatment of Superficial Femoral Artery Disease: A Network Meta-analysis. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101827. DOI: 10.1016/j.jscai.2024.101827.
• F-12 | Endovascular versus surgical revascularization for patients with chronic limb threatening ischemia: A systematic review and meta-analysis of randomized controlled trialsBalakrishna A, Alla V, Aronow H, Secemsky E, Altin S, Jayasuriya S, Goldsweig A. F-12 | Endovascular versus surgical revascularization for patients with chronic limb threatening ischemia: A systematic review and meta-analysis of randomized controlled trials. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101821. DOI: 10.1016/j.jscai.2024.101821.
• E-2 | Prevalence and Clinical Correlates of Obstructive Sleep Apnea on In-hospital Outcomes following Transcatheter Aortic Valve Replacement: Results from National Inpatient Sample Database 2016-2020Aggarwal A, Garcia A, Vasquez M, Vardhan S, Ahmed A, Vardhan M, Batlle J, Zarich S, Davila C. E-2 | Prevalence and Clinical Correlates of Obstructive Sleep Apnea on In-hospital Outcomes following Transcatheter Aortic Valve Replacement: Results from National Inpatient Sample Database 2016-2020. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101758. DOI: 10.1016/j.jscai.2024.101758.
• Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic MedicationsYoung G, Bansal K, Riello R, Clark K, Dhruva S, Faridi K, Desai N. Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications. JAMA Network Open 2024, 7: e2412437. PMID: 38771578, PMCID: PMC11109768, DOI: 10.1001/jamanetworkopen.2024.12437.
• MP-470550-005 FEASIBILITY OF AMULET IMPLANTATION AFTER FAILED LAAO ATTEMPT: INSIGHTS FROM THE EMERGE LAA POST-APPROVAL STUDYMakkar A, Alkhouli M, Ellis C, Shah A, coylewright M, Freeman J, Lakkireddy D. MP-470550-005 FEASIBILITY OF AMULET IMPLANTATION AFTER FAILED LAAO ATTEMPT: INSIGHTS FROM THE EMERGE LAA POST-APPROVAL STUDY. Heart Rhythm 2024, 21: s97. DOI: 10.1016/j.hrthm.2024.03.457.
• B-40 | Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac ProcedureIsmayl M, Ahmed H, Freeman J, Alkhouli M, Lakkireddy D, Goldsweig A. B-40 | Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac Procedure. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 3: 101607. DOI: 10.1016/j.jscai.2024.101607.
• Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United StatesRymer J, Narcisse D, Chen A, Wojdyla D, Ashley S, Damluji A, Shah B, Nanna M, Swaminathan R, Gutierrez J, Uzendu A, Nelson A, Bethel G, Kearney K, Jones W, Rao S, Doll J. Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States. Journal Of The American College Of Cardiology 2024, 83: 1990-1998. PMID: 38749617, PMCID: PMC11173360, DOI: 10.1016/j.jacc.2024.03.395.
• Hypertension Trends and Disparities Over 12 Years in a Large Health System: Leveraging the Electronic Health Records.Brush J, Lu Y, Liu Y, Asher J, Li S, Sawano M, Young P, Schulz W, Anderson M, Burrows J, Krumholz H. Hypertension Trends and Disparities Over 12 Years in a Large Health System: Leveraging the Electronic Health Records. Journal Of The American Heart Association 2024, 13: e033253. PMID: 38686864, PMCID: PMC11179912, DOI: 10.1161/jaha.123.033253.
• Hospital Variation in the Use of Intravenous Benzodiazepines for Sedation During Early Mechanical VentilationJain S, Gershengorn H, Priya A, Walkey A, Burry L, Krumholz H, Wunsch H, Lindenauer P. Hospital Variation in the Use of Intravenous Benzodiazepines for Sedation During Early Mechanical Ventilation. 2024, a1095-a1095. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1095.
• Hospital Variation in Delivery of Skilled Rehabilitation to Mechanically Ventilated Older Adults With Acute Respiratory FailureJimenez Ceja J, Zhang L, Lin Z, Walkey A, Krumholz H, Jain S. Hospital Variation in Delivery of Skilled Rehabilitation to Mechanically Ventilated Older Adults With Acute Respiratory Failure. 2024, a1096-a1096. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a1096.
• Update in genetic and epigenetic causes of hypertensionMani A. Update in genetic and epigenetic causes of hypertension. Cellular And Molecular Life Sciences 2024, 81: 201. PMID: 38691164, PMCID: PMC11062952, DOI: 10.1007/s00018-024-05220-4.
• Extracellular Cyclic AMP Suppresses Pulmonary Arterial Hypertension-induced Ventricular ArrhythmiasImani S, Strauss B, Obus E, Cacheux M, Hadri L, Akar F, Sassi Y. Extracellular Cyclic AMP Suppresses Pulmonary Arterial Hypertension-induced Ventricular Arrhythmias. 2024, a4051-a4051. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a4051.
• Three-dimensional (3D) Right Ventricular Surface Strain Computed From 3D Echocardiography Correlates With RVEF and Reveals Differences in Deformation Based on Severity of Pulmonary Arterial Hypertension SymptomsOakland H, Bellumkonda L, Sugeng L, Joseph P, Izzi D, Zalik F, McCabe S, Raza A, Amendola R, Heerdt P, Singh I, Hunter K. Three-dimensional (3D) Right Ventricular Surface Strain Computed From 3D Echocardiography Correlates With RVEF and Reveals Differences in Deformation Based on Severity of Pulmonary Arterial Hypertension Symptoms. 2024, a7381-a7381. DOI: 10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a7381.
• Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysisJhand A, Abusnina W, Tak H, Ahmed A, Ismayl M, Altin S, Sherwood M, Alexander J, Rao S, Abbott J, Carson J, Goldsweig A. Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis. International Journal Of Cardiology 2024, 408: 132111. PMID: 38697401, DOI: 10.1016/j.ijcard.2024.132111.
• Local large language models for privacy-preserving accelerated review of historic echocardiogram reportsVaid A, Duong S, Lampert J, Kovatch P, Freeman R, Argulian E, Croft L, Lerakis S, Goldman M, Khera R, Nadkarni G. Local large language models for privacy-preserving accelerated review of historic echocardiogram reports. Journal Of The American Medical Informatics Association 2024, ocae085. PMID: 38687616, DOI: 10.1093/jamia/ocae085.
• Quantitative Assessment of Mitochondrial Morphology and Electrophysiological Function in the Diabetic HeartCacheux M, Rudokas M, Tieu A, Rizk J, Hummel M, Akar F. Quantitative Assessment of Mitochondrial Morphology and Electrophysiological Function in the Diabetic Heart. 2024, 2803: 75-86. PMID: 38676886, DOI: 10.1007/978-1-0716-3846-0_6.
• Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States PracticeBharadwaj A, Truesdell A, Lemor A, Thompson J, Abu-Much A, Zhang Y, Schonning M, Cohen D, Lansky A, O'Neill W. Characteristics of Patients Undergoing High-Risk Percutaneous Coronary Intervention in Contemporary United States Practice. The American Journal Of Cardiology 2024, 222: 8-10. PMID: 38679222, DOI: 10.1016/j.amjcard.2024.04.042.
• Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach.Regan C, Scierka L, Dardik A, Tonnessen B, Iyad Ochoa Chaar C, Ionescu C, Aboian E, Cardella J, Nassiri N, Guzman R, Attaran R, Nagpal S, Shah S, Smolderen K, Mena-Hurtado C. Clinician perspectives regarding CYP2C19 genotype testing in patients with critical limb ischemia: A Delphi approach. Vascular 2024, 17085381241246318. PMID: 38669051, DOI: 10.1177/17085381241246318.
• Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking ProgramGonzalez P, Hebbe A, Hussain Y, Khera R, Banerjee S, Plomondon M, Waldo S, Pfau S, Curtis J, Shah S. Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program. The American Journal Of Cardiology 2024, 222: 39-50. PMID: 38677666, DOI: 10.1016/j.amjcard.2024.04.039.
• Long COVID Characteristics and Experience: A Descriptive Study from the Yale LISTEN Research CohortSawano M, Wu Y, Shah R, Zhou T, Arun A, Khosla P, Kaleem S, Vashist A, Bhattacharjee B, Ding Q, Lu Y, Caraballo C, Warner F, Huang C, Herrin J, Putrino D, Michelsen T, Fisher L, Adinig C, Iwasaki A, Krumholz H. Long COVID Characteristics and Experience: A Descriptive Study from the Yale LISTEN Research Cohort. The American Journal Of Medicine 2024 PMID: 38663793, DOI: 10.1016/j.amjmed.2024.04.015.
• Corrigendum: Outcomes among Neonates after a Diagnosis of Persistent or Transient Fetal Growth Restriction Delivered at TermRamos S, Has P, Gimovsky A, Danilack V, Savitz D, Lewkowitz A. Corrigendum: Outcomes among Neonates after a Diagnosis of Persistent or Transient Fetal Growth Restriction Delivered at Term. American Journal Of Perinatology 2024, 41: e1478-e1478. PMID: 38653454, DOI: 10.1055/s-0044-1786526.
• Endothelial HIFα-PDGF-B to smooth muscle Beclin1 signaling sustains pathological muscularization in pulmonary hypertensionSaddouk F, Kuzemczak A, Saito J, Greif D. Endothelial HIFα-PDGF-B to smooth muscle Beclin1 signaling sustains pathological muscularization in pulmonary hypertension. JCI Insight 2024, 9: e162449. PMID: 38652543, PMCID: PMC11141934, DOI: 10.1172/jci.insight.162449.
• Trends in Age, Sex, and Racial Differences in the Incidence of Infective Endocarditis in Florida and New YorkAnuforo A, Aneni E, Akintoye E, Anikpezie N, Patel S, Soipe A, Olojakpoke E, Burke D, Latorre J, Khandelwal P, Chaturvedi S, Ovbiagele B, Otite F. Trends in Age, Sex, and Racial Differences in the Incidence of Infective Endocarditis in Florida and New York. Circulation 2024, 149: 1391-1393. PMID: 38648273, DOI: 10.1161/circulationaha.123.066921.
• Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysisBonomi P, Crawford J, Dunne R, Roeland E, Smoyer K, Siddiqui M, McRae T, Rossulek M, Revkin J, Tarasenko L. Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysis. Journal Of Cachexia Sarcopenia And Muscle 2024 PMID: 38650388, DOI: 10.1002/jcsm.13477.
• Factors Associated with Long COVID Recovery among US AdultsShah K, Shah R, Sawano M, Wu Y, Bishop P, Iwasaki A, Krumholz H. Factors Associated with Long COVID Recovery among US Adults. The American Journal Of Medicine 2024 PMID: 38649004, DOI: 10.1016/j.amjmed.2024.04.017.
• Physiological Assessment with iFR prior to FFR Measurement in Left Main DiseaseWarisawa T, Cook C, Ahmad Y, Howard J, Seligman H, Rajkumar C, Toya T, Doi S, Nakajima A, Nakayama M, Vera-Urquiza R, Yuasa S, Sato T, Kikuta Y, Kawase Y, Nishina H, Al-Lamee R, Sen S, Lerman A, Matsuo H, Akashi Y, Escaned J, Davies J. Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease. Cardiovascular Intervention And Therapeutics 2024, 39: 241-251. PMID: 38642290, PMCID: PMC11164744, DOI: 10.1007/s12928-024-00989-4.
• 1087 Recognizing Sleep Disorders in the US Military Health System: Differences Between On-base and Private Sector CareCapaldi V, Williams S, Thomas C, Herrin J, Hong A, Funk W, Collen J, Stryckman B, Albrecht J, Wickwire E. 1087 Recognizing Sleep Disorders in the US Military Health System: Differences Between On-base and Private Sector Care. Sleep 2024, 47: a467-a467. DOI: 10.1093/sleep/zsae067.01087.
• Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical TrialShah N, Ghazi L, Yamamoto Y, Kumar S, Martin M, Simonov M, Riello Iii R, Faridi K, Ahmad T, Wilson F, Desai N. Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID): A Randomized Clinical Trial. Circulation Cardiovascular Quality And Outcomes 2024, 17: e010335. PMID: 38634282, DOI: 10.1161/circoutcomes.123.010335.
• Patient-specific ascending aortic intervention criteriaKalogerakos P, Zafar M, Li Y, Ellauzi H, Mukherjee S, Ziganshin B, Rizzo J, Elefteriades J. Patient-specific ascending aortic intervention criteria. European Journal Of Cardio-Thoracic Surgery 2024, 65: ezae162. PMID: 38632077, DOI: 10.1093/ejcts/ezae162.
• Transcatheter or Surgical Aortic Valve Replacement in Women With Small Annuli at Low or Intermediate Surgical RiskModine T, Forrest J, Van Mieghem N, Deeb G, Yakubov S, Ali W, Tchétché D, Lam K, Oh J, Huang J, Mehran R, Reardon M. Transcatheter or Surgical Aortic Valve Replacement in Women With Small Annuli at Low or Intermediate Surgical Risk. The American Journal Of Cardiology 2024, 223: 147-155. PMID: 38641189, DOI: 10.1016/j.amjcard.2024.04.013.